M&A Deal Summary |
|
|---|---|
| Date | 2021-12-20 |
| Target | Spray-Tek |
| Sector | Chemicals |
| Buyer(s) | Aurora Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Advisor(s) | KeyBanc Capital Markets (Financial) McDermott Will & Emery (Legal) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1991 |
| PE ASSETS | 4.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Aurora Capital Partners is a private investment firm that manages private equity funds as well as investment vehicles focused on debt/equity securities. Targeted businesses are generally industry leaders that operate in defensible markets with sustainable margins. Sectors of interest include aerospace, industrial products, and services, packaging, plastics, distribution, manufacturing, media, retail, and chemicals. Aurora will only consider majority/control positions. Aurora's investment horizon is typically three to seven years. Aurora Capital Partners was formed in 1991 and is based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 36 of 43 |
| Sector: Chemicals M&A | 4 of 5 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 11 of 13 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 35 of 42 |
| Year: 2021 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-16 |
IronSite
Corona, California, United States IronSite provides automated gate and security solutions, including emergency repair, planned maintenance, design, fabrication, access control and installation to residential and commercial customers across Southern California. IronSite was founded in 1998 and is based in Corona, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-11 |
Pace
Minneapolis, Minnesota, United States Pace is a provider of analytical testing and related outsourced scientific solutions to the life sciences industry. Pace's Analytical Services division provides full-service testing, sampling, and analytical support services to detect trace-level organic and inorganic contaminants in air, water, wastewater, soil, biota, and waste. Pace's Life Sciences division provides a wide variety of testing services for the biopharmaceutical, pharmaceutical, medical device, and drug-device industries as well as early-stage drug development and manufacturing services with a broad range of pre-clinical and clinical capabilities for both small and large molecules. Pace was formed in 1978 and is based in Minneapolis, Minnesota. |
Sell | - |
